The stock of ConforMIS Inc (NASDAQ:CFMS) is a huge mover today! About 100,464 shares traded hands. ConforMIS Inc (NASDAQ:CFMS) has declined 2.28% since March 7, 2016 and is downtrending. It has underperformed by 9.87% the S&P500.
The move comes after 6 months positive chart setup for the $449.34 million company. It was reported on Oct, 10 by Barchart.com. We have $23.59 PT which if reached, will make NASDAQ:CFMS worth $534.71M more.
Analysts await ConforMIS Inc (NASDAQ:CFMS) to report earnings on November, 7. They expect $-0.35 EPS, up 22.22% or $0.10 from last year’s $-0.45 per share. After $-0.34 actual EPS reported by ConforMIS Inc for the previous quarter, Wall Street now forecasts 2.94% negative EPS growth.
ConforMIS Inc (NASDAQ:CFMS) Ratings Coverage
Out of 9 analysts covering ConforMIS Inc (NASDAQ:CFMS), 7 rate it a “Buy”, 0 “Sell”, while 2 “Hold”. This means 78% are positive. ConforMIS Inc has been the topic of 16 analyst reports since July 27, 2015 according to StockzIntelligence Inc. On Monday, July 27 the stock rating was initiated by JP Morgan with “Overweight”. Deutsche Bank initiated the shares of CFMS in a report on Monday, July 27 with “Buy” rating. The firm has “Market Perform” rating given on Friday, May 13 by Wells Fargo. Oppenheimer initiated ConforMIS Inc (NASDAQ:CFMS) on Monday, July 27 with “Outperform” rating. The stock of ConforMIS Inc (NASDAQ:CFMS) earned “Neutral” rating by JP Morgan on Friday, May 13. The firm earned “Outperform” rating on Wednesday, August 12 by Oppenheimer. As per Tuesday, August 9, the company rating was maintained by Oppenheimer. As per Monday, July 27, the company rating was initiated by Wells Fargo. The rating was initiated by Sterne Agee CRT on Tuesday, December 1 with “Buy”. As per Tuesday, August 9, the company rating was maintained by JP Morgan.
According to Zacks Investment Research, “ConforMIS, Inc. is a medical technology company which develops, manufacture and sells joint replacement implants. The Company’s iFit technology platform consists of iFit Design, iFit Printing and iFit Just-in-Time Delivery. It operates primarily in the United States, Germany and the United Kingdom. The Company serves orthopedic surgeons, hospitals and other medical facilities and patients. ConforMIS, Inc. is based in Bedford, United States.”
More notable recent ConforMIS Inc (NASDAQ:CFMS) news were published by: Marketwatch.com which released: “/quotes/zigman/3870025/realtime” on May 30, 2015, also Marketwatch.com with their article: “Conformis shares plunge more than 30% on cut outlook, CEO search” published on May 12, 2016, Quotes.Wsj.com published: “ConforMIS Inc. CFMS (US: Nasdaq)” on June 30, 2015. More interesting news about ConforMIS Inc (NASDAQ:CFMS) were released by: Nasdaq.com and their article: “Archived Event: ConforMIS, Inc. (CFMS), Interview with Philipp Lang, CEO” published on July 27, 2015 as well as Bostonglobe.com‘s news article titled: “ConforMIS taking a custom-fit approach to joint replacements” with publication date: August 18, 2015.
CFMS Company Profile
ConforMIS, Inc., incorporated on March 26, 2004, is a medical technology firm that uses its iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants that are individually sized and shaped. The Company’s products include iTotal, iTotal PS, iDuo and iUni. The Company’s iFit technology platform comprises three elements: iFit Design, iFit Printing and iFit Just-in-Time Delivery. iFit Design is the Company’s algorithms and computer software that it uses to design customized implants and associated single-use, patient-specific instrumentation, which is referred to as iJigs. iJigs is based on a computed tomography (CT) scan of the patient and to prepare a surgical plan customized for the patient that it calls iView. iFit Printing is a three-dimensional (3D) printing technology that the Company uses to manufacture iJigs. iFit Just-in-Time Delivery is its just-in-time manufacturing and delivery capability. The Firm markets and sells its products in the United States, Germany, the United Kingdom, Austria, Ireland, Switzerland, Singapore and Hong Kong.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.